Applying justice in clinical trials for diverse populations.
| Autor: | Tilburt J; Department of Clinical Bioethics, National Institutes of Health, Bethesda, MD, USA. tilburtj@cc.nih.gov, Ford JG, Howerton MW, Gary TL, Lai GY, Bolen S, Baffi C, Wilson RF, Tanpitukpongse TP, Powe NR, Bass EB, Sugarman J |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical trials (London, England) [Clin Trials] 2007; Vol. 4 (3), pp. 264-9. |
| DOI: | 10.1177/1740774507079440 |
| Abstrakt: | Background: Considerable attention has focused on increasing clinical trial participation for members of "underrepresented groups". However, doing so involves clarifying how to meet the demands of justice, or fairness, which provides the ethical mandate to enhance broad trial representation. Purpose: To examine the ethical principle of justice as it applies to recruiting diverse populations to clinical trials representation. Methods: In this paper, we analyse the conceptual and practical challenges in applying the principle of justice to clinical trials representation. Results: Different facets of justice include demands for both fair outcomes and fair processes. Including both of these facets in clinical trials policy should not only promote access to trials, but also help to provide a framework to improve fairness in representation in clinical trials. Efforts to evaluate recruitment of representation should include outcome and process measures. Limitations: The suggestions offered based on this conceptual analysis need to be tested empirically. Conclusions: Those involved in the design, conduct and oversight of clinical trials should consider all of the facets of justice when assessing representation in clinical trials and attempt to balance fair access to trials with a fair process that may require protection from being unduly pressured to participate. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|